TCP
BMY icon

Tourbillon Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History

Tourbillon Capital Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-250,000
Closed -$17.2M – 68
2015
Q4 		$17.2M Buy
+250,000
New +$16.5M 0.39% 49

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Tourbillon Capital Partners's BMY Position: Q1 2016 in Review

Tourbillon Capital Partners sold out of Bristol-Myers Squibb (BMY) in Q1 2016, closing a stake of 1,275,000 shares — an estimated $87.7M sold.

Tourbillon Capital Partners first reported a position in BMY in Q4 2015 and held it in 1 quarter. The position peaked at $87.7M in Q4 2015. 1,524 funds tracked by Wall St. Rank hold BMY as of Q1 2016.

  • Tourbillon Capital Partners reported no remaining Bristol-Myers Squibb position as of Q1 2016 after selling out during the quarter.
  • Tourbillon Capital Partners sold 1,275,000 Bristol-Myers Squibb shares in Q1 2016, an estimated $87.7M.
  • Tourbillon Capital Partners first reported a position in Bristol-Myers Squibb in Q4 2015 and held it in 1 quarter.
  • Tourbillon Capital Partners's Bristol-Myers Squibb position peaked at $87.7M in Q4 2015.
  • 1,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2016.

Based on Tourbillon Capital Partners's 13F filing for Q1 2016, filed 16 May 2016.